Luther Elliott
Luther C. Elliott, PhD
NYU School of Global Public Health - Associate Research Scientist
Post-Doctoral Fellowship, Substance Abuse, Behavioral Science Training Program, NDRI, Inc.
PhD, Anthropology, New York University
MA, Anthropology, New York University
BA, English/French, University of Connecticut, Storrs
Research Interests
Opioid dependence and overdose, Substance use careers, Interactive media, Non-traditional treatment paradigms, Behavioral "addictions", Ethnographic methods, Psychedelics
Luther Elliott is a cultural and medical anthropologist who focuses on pathways to substance misuse and behavioral addictions. Dr. Elliott’s interests in vulnerable subcultures and populations led him to the Institute for Special Populations Research (ISPR) at NDRI following his PhD work (New York University, 2006) with emergent subcultures of psychedelic drug use. Since then, he has collaborated with senior researchers, Bruce Johnson, Eloise Dunlap, and Andrew Golub on studies of marijuana use (R01DA013690), Hurricane Katrina’s evacuees (R01DA021783), and veterans’ health (R01AA020178). Dr. Elliott recently served as principal investigator on a 3-year study of developmental relationships between video game and substance use (R01DA027761) and is currently serving as co-investigator on a study of opioid treatment program disruption in the wake of Hurricane Sandy (6HITEP140014-01-03) and Co-Investigator and Project Director on a prospective study of military veterans’ overdose risks and prevention efforts (R01DA036754).
Principal Investigator, Evaluation of a Community-Based Education, Navigation, and Support (CENS) Intervention to Reduce Opioid-Related Harms Among Military Veterans. Active
Principal Investigator, Exploratory Mapping of Kratom Use Patterns and Markets in NYC. Active
Principal Investigator, Overdose Risk Management and Compensation in the Era of Naloxone. Active


Bennett AS, Townsend T, Elliott L (2022).
The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months
International Journal of Drug Policy, 101, 103554. doi: 10.1016/j.drugpo.2021.103554. PMCID: PMC8632599.

Bennett AS, Elliott L (2021).
Naloxone’s role in the national opioid crisis – past struggles, current efforts, and future opportunities
Translational Research, 234, 43-57. doi: 10.1016/j.trsl.2021.03.001. PMCID: PMC8327685.

Elliott L, Crasta D, Khan M, Roth A, Green T, Kolodny A, Bennett AS (2021).
Validation of the Opioid Overdose Risk Behavior Scale, version 2 (ORBS-2)
Drug and Alcohol Dependence, 223, 108721. doi: 10.1016/j.drugalcdep.2021.108721. PMCID: PMC8113089.

Cleland CM, Bennett AS, Elliott L, Rosenblum A, Britton PC, Wolfson-Stofko B (2020).
Between- and within-person associations between opioid overdose risk and depression, suicidal ideation, pain severity, and pain interference
Drug and Alcohol Dependence, 206, 107734. doi: 10.1016/j.drugalcdep.2019.107734. PMCID: PMC6980716.

Elliott L, Haddock CK, Campos S, Benoit E (2019).
Polysubstance use patterns and novel synthetics: A cluster analysis from three U.S. cities
PLoS One, 14 (12), e0225273. doi: 10.1371/journal.pone.0225273. PMCID: PMC6890248.

Dr. Elliott's Google Scholar Profile